FDA’s authorization of non-opioid pain killer might be game-changer

The Federal Medicine Management authorized a brand-new sort of non-additive pain reliever, Journavx, last month. The physicians state publications are a crucial option due to the fact that the power of opioids aids with overdose upsurges and rise in fentanyl usage. Stephanie Stahl records.